Skip to main content
FinSpry Logo
FinSpry
NVAX logo
NVAX
(NASDAQ)
Novavax, Inc.
$7.70-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novavax (NVAX) Stock Price & Financial Analysis

Novavax Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.57 - $7.91
52-Week High$11.97
52-Week Low$5.01
Open$7.70
Volume4.65M
Average Volume (3M)4.65M
Market Cap1.33B
Shares Outstanding173.10M
P/E Ratio (TTM)3.15
Price to Sales (P/S)1.28
EV/EBITDA2.84
Revenue (TTM)1.08B
Net Income (TTM)440.30M
Free Cash Flow (TTM)-250.85M
EPS (TTM)$2.54
Profit Margin40.65%
Operating Margin51.39%
50-Day MA$9.37
200-Day MA$8.03
52-Week Change33.67%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Novavax

What is the current stock price for NVAX?

As of the latest trading session, NVAX stock trades at $7.70. The 52-week range is $5.01–$11.97, with a day range of $7.57–$7.91.

What is the P/E ratio for NVAX?

Novavax's trailing P/E ratio is 3.1, meaning investors pay $3.1 for every $1 of annual earnings. Novavax operates in the Healthcare sector.

Does NVAX pay dividends?

Novavax does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVAX?

Based on 3 analysts, the consensus for NVAX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NVAX?

Novavax's market capitalization is $1.33B, classifying it as a small-cap company. Novavax operates in the Healthcare sector within the Biotechnology industry.